“…Designations: *, base pairs partially resistant to nuclease without any protein (indicated if at least three consecutive bases are resistant); black line, phosphodiester bonds protected against DNase digestion by RNA polymerase; gaps, unprotected base pairs; dashed line, regions protected by activator molecule; filled triangles, hypereactive base pairs (V, base pairs whose hyperreactivity was estimated by FUTPR and is not discussed in the original papers); *, promoter complexes that were not analyzed by FUJTPR. References to original papers and discrepancies: pap (24); tyrT (25); merPR (26); galPl(9A16C) and 9A16C(-1) (27); galPl(19T) (28, agrees with 19); galPl(19T, constructs d and g) (8); gaIP3 (29);fdPVIll (30); D108Pe (31); rmBPl (+ATP and CTP) (18, agrees with 32); rmBPl (UAR deleted) (+ATP and CTP) (32); T7D (33); Tn3 bla (34, agrees with 35), but hyperreactivity at -27 is not registered); lacPl(L8UV5) (36), additional hyperreactivity at-48 was registered in (37); lacPl(UV5) (38, agrees with 39-41), additional hyperreactivity at +18 registered in (42), hyperreactivity at -49 was not registered in (43); tac/pT T7 (44); aroG (45); XPR(PRM 1 16) (46, agrees with 47 for (PR); XPRMA34(PRX3) (46); tetR (48); lacP2 (36); T7A3 (43); lacPrl 15 (37); deoPl (49); gaIP2 (28, agrees with 50); crp (51); groE, dnaKP2 and rpoDpHS (52); lacPl (UV5)+CRP-cAMP (40); mll+CRP-cAMP (53); D108Pe+IHF (31); galPl+CRP-cAMP (50); galPl(9A16C)+CRP-cAMP (27); katG+OxyR (54), merPT+MerR-Hg (26); malP+MalT (55); P22Pa23+P22 Cl (56);…”